FMO5 and Hyperglycemia: It has been postulated that hyperglycemia, a key clinical manifestation of diabetes, may produce ROS through the formation of advanced glycation end products (AGEs) [11, 12] and altered polyol pathway activity [13], and through the activation of NADPH oxidase via protein kinase C (PKC) [15].